Diabetes: Management Flashcards
How often does a diabetic review occur? [1]
State 6 factors reviewed in a diabetic review [6]
Every person with diabetes should be seen at least twice a year
The Diabetes Annual Review should include:
▪ Review of symptoms
▪ Review clinical issues
▪ Weight / BMI
▪ Glucose levels
▪ Blood pressure
▪ Cholesterol
▪ Creatinine (eGFR) + urine albumin creatinine ratio (ACR)
What BP in DM patients would indicate BP treatment? [1]
What BP for a diabetic patient would indicate BP treatment if they have kidney, eye or CV disease ? [1]
BP persistantly over 140 / 90 mmHG
BP persistantly over 130 / 80 mmHG & kidney, eye or CV disease
What drug, dose and administration would you give to DMT2 patients with no CVD, but Qrisk score of greater than 10% to modify their lipid levels? [1]
What drug, dose and administration would you give to DMT2 patients with known CVD modify their lipid levels? [1]
If not achieving target, which drugs should be prescribed modify their lipid levels? [2]
Diabetic patients with no CVD, but Qrisk score of greater than 10%:
- Arvostatin, 20mg daily
Diabetic patients with known CVD:
- Arvostatin, 80mg daily
No response:
- Ezetimibe
- PCSK9 inhibitors
When should you provide statins for DMT1 patients? [2]
- Anyone who has has DMT1 for over 10 years
- Statins for anyone with complications (eyes / neuro etc
Describe the physiological effect for long term diabetic management of having tight glycaemic control [2]
Microvascular complications reduced
Macrovascular complications has no effect
Which conditions are HbA1c may be invalid for when assessing diabetic conditions? [2]
May be invalid in haemoglobinopathy or anaemia (reduced red blood cell survival)
What substance can be used if HbA1c is invalid to assess glycaemic control? [1]
Fructosamine (Another glycated protein, lasts around 2 weeks)
How can patients using insulin therapy assess their glycaemic control? [1]
What are pre-prandial and post-prandial glucose level aims? [2]
Self monitoring of blood glucose (SMBG):
Pre-prandial aim: 4-7 mmol/L
Post-prandial aim: 5-9 mmol/L
Name this [1]
Which Ptx populations can use it? [4]
Intermittently Scanned Continuous Glucose Monitoring (Freestyle Libre)
▪ Can be used in most people with T1D
▪ Consider in people with T2D if they are on
twice daily or more insulin therapy
▪ AND have recurrent hypos or severe hypos or hypo unawareness
▪ OrLearningdisability/Cognitiveimpairment
Which patient populations are the only group given Continuous Glucose Monitoring? [1]
Suffer from hypoglycaemic unawareness
DMT2 Management:
- MoA of Metformin? [3]
- Acts by activation of the AMP-activated protein kinase (AMPK)
- Increases insulin sensitivity / improving insulin resistance
- Decreases hepatic gluconeogenesis
- inhibits glucose absorption in the gut
DMT2 Management:
Advantages [4] and Disadvantages [2] of Metformin?
Advantages:
- Rapid & effective
- No effect on weight
- Insulin sparing
- Useful pregnant population
- Cheap
Disadvantages:
- Can cause lactic acidosis in renal / liver disease patients
- GI effects (nausea, anorexia, diarrhoea), intolerable in 20%.
Which diabetic drug class works by the MoA:
Works by stimulating insulin release from the beta cells (non- glucose dependent)
Sulfonylureas
Sulfonylurea works by which MoA? [1]
Works by stimulating insulin release from the beta cells (non- glucose dependent)
State 2 advantages of sulfonylureas
State 3 disadvantages of sulfonylureas
Advantage:
Oral
Cheap
Disadvantage
Hypoglycaemia
Weight gain
Testing glucose if driving
Describe the MoA of Acarbose [2]
Blocks disaccharidase in the GI tract
Reduces absorption of glucose }
State two disadvantages of acarbose
- Bloating (due to fermentation of glucose
- Not very effective
Works to improving insulin sensitivity by binding to PPAR- gamma refers to which diabetic drug class? [1]
Glitazones (thiazolidinediones)
Name 3 advantages of glitazones for diabetic control
Generally well tolerated
Oral / once daily
Cheap - ~ £2.00 per month
HbA1c reduction 10-15 mmol/mol
Little hypoglycaemia
Name 4 disadvantages of glitazones (thiazolidinediones) [4]
Oedema (avoid in HF)
Weight gain 3-5 kg
Fractures in post menopausal women
Query around cause of bladder cancer
ELBOW
Edema
Liver failure
Bladder cancer
Osteoporosis
Weight gain
Describe the physiological effect of GLP-1 [4]
Glucose-dependently stimulates insulin secretion and decreases glucagon secretion:
Delays gastric emptying
Decreases food intake and induces satiety
Stimulates B-cell function and preserves or increases B-cell mass in animal models (stimulating insulin release)
Name a daily [1] & weekly [2] injectable GLP-1 drug
Liraglutide – daily injection
Dulaglutide – weekly injection
Semaglutide – weekly injection or oral tablet